VISEN PHARMA-B

2561
12.5600.80% ( +0.100 )
Delay Closed: Nov 16, 16:08:00

Financials

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: VISEN PHARMA-B(02561) the Revenue is 20.1 M (+4037%);the EBIT is -51.06 M (+11.9%);the EPS is -0.55 (+14.83%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.02B4036.99%
----
----
EBIT
-0.05B11.90%
----
----
EPS
-0.550414.83%
----
----

Upcoming earnings report - FY2026 Q3 Earning Release

Available dateNov 27, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly